Fight Obesity with Diet Pills : Fine Generics

Fight Obesity with Diet Pills
In the year 1999, almost 97 million adult People were overweight or obese. And in the year 2000, the most shocking statistical data - 400,000 People died due to poor diet and physical inactivity...

In the year 1999, almost 97 million adult People were overweight or obese. And in the year 2000, the most shocking statistical data - 400,000 People died due to poor diet and physical inactivity. This was the largest increase among all actual causes of death.

According to the online weight loss information available, being overweight or obese puts the person at serious risk for developing many obesity related diseases. Excess weight puts a strain on the heart and one is likely to develop heart disease even if they don't have other risk factors Heart attack is the most visible sign of heart disease which is the leading cause of death today.

Carrying extra weight puts a strain on our circulatory system, increasing our risk for stroke. Stroke can result in limb weakness, paralysis of one side of the body, difficulty speaking and processing language, and even death.

Type 2 Diabetes may be the chronic health condition most closely linked to being overweight. It is the seventh leading cause of death and can lead to other serious health problems including heart disease, blindness and kidney failure

A higher body weight increases the risk of high blood pressure. If left untreated, hypertension can cause heart attack, stroke and kidney failure. Other Health Risks Obesity substantially increases the risk of developing many other chronic health conditions such as gall bladder disease, breast cancer, prostate cancer, colon cancer sleep apnea, osteoarthritis and respiratory problems. The higher the body weight, the higher the risk of premature death from all causes.

One of the most effective therapies to fight weight loss is Diet Pills. The effectiveness of diet pills has been intensively studied by many international organisations and research institutes. Unfortunately this research has never been published in a suitable way to help the patient compare the different diet pills and weight loss products available on the market. There is however a few diet pills that really stand out.

Xenical is a weight loss medication based on Orlistat, which acts as a lipase inhibitor by letting part of the fat consumed pass through the intestine without being absorbed. Xenical has proven to be effective and especially suitable for patients suffering from diabetes, high blood pressure or heart disease, as it is not affecting the patients metabolic rate.

If one eats an excessive amount of fat or calories, the excess is stored as fat by the body, resulting in weight gain. When one eats fat, your body breaks it down into its simplest components so that it can be digested.

Unlike other weight-loss drugs you may have heard about that act in the brain or central nervous system to suppress appetite or to speed up metabolism, Xenical works in our digestive system to block about one-third of the fat in the food you eat from being digested.

Enzymes in your digestive system, called lipases, help digest (or break down) fat. When taken with meals, Xenical attaches to the lipases and blocks them from breaking down some of the fat you have eaten.

The undigested fat cannot be absorbed and is eliminated in your bowel movements. By working this way, Xenical helps block about one-third of the fat in the foods you eat from being absorbed by your body.

Meridia is a prescription medication that's used along with a reduced-calorie diet and exercise to help promote and maintain weight loss by working on the appetite control centers in the brain.

What's more, Meridia has been extensively studied for the treatment of obesity. And among the encouraging data that resulted from that research was evidence that using Meridia, along with a reduced-calorie diet and exercise, may help patients lose weight and maintain weight loss for up to 2 years.

Meridia works by acting on the appetite control center in the brain. Studies have shown that using Meridia, along with a reduced-calorie diet and exercise, helped patients lose weight and maintain weight loss for up to two years. The active ingredient in Meridia, sibutramine, works in the area of the brain that signals the sense of fullness (satiety) Meridia does not suppress appetite, which is your signal to start eating.

Meridia blocks the re-uptake of the brain chemicals (serotonin and norepinephrine) which help regulate the sense of fullness. 1 Fullness is your signal to stop eating. Having a sense of fullness, or satiety, means you may feel satisfied with less food. Sibutramine should be used in conjunction with a reduced calorie diet. Always consult your physician before beginning any diet or exercise program.3

Sibutramine, the active ingredient in Meridia, has been extensively studied throughout the world. It has been studied in more than 100 clinical trials involving more than 12,000 patients. Approximately 14 million patients in more than 75 countries have used sibutramine for the treatment of obesity since it was approved in 1997.

In studies, sibutramine in combination with diet and exercise was effective in producing and maintaining significant weight loss in the majority of obese patients compared to diet and exercise alone.2

Meridia is recommended for overweight people with an initial Body Mass Index (BMI) of 30 or higher or overweight people with a BMI of 27 or higher if they have medical risk factors such as high blood pressure, diabetes, or high cholesterol.

On the other hand there is Didrex which contains the anorectic agent benzphetamine hydrochloride. Each Didrex Tablet, for oral administration, contains 50 mg of benzphetamine hydrochloride.

Benzphetamine hydrochloride is a sympathomimetic amine with pharmacologic activity similar to the prototype drugs of this class used in obesity, the amphetamines. Drugs of this class used in obesity are commonly known as "anorectics" or "anorexigenics". It has not been established, however, that the action of such drugs in treating obesity is primarily one of appetite suppression. Other central nervous system actions, or metabolic effects, may be involved.

Adult obese subjects instructed in dietary management and treated with "anorectic" drugs, lose more weight on the average than those treated with placebo and diet, as determined in relatively short-term clinical trials.

Didrex Tablets are indicated in the management of exogenous obesity as a short term adjunct (a few weeks) in a regimen of weight reduction based on caloric restriction. The limited usefulness of agents of this class should be weighed against possible risks inherent in their use such as those described below.